Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Serum total an unbound testosterone (T) and sex hormone binding globulin (SHBG) levels were studied in fifty-four female acne patients before treatment and during the treatment by two different oral contraceptives, the other containing 0.150 mg desogestrel plus 0.03 mg EE and the other 0.150 mg levonorgestrel plus 0.03 mg EE. Pretreatment values were abnormal in 57% of the patients. A borderline significant correlation between the severity of acne and SHBG was found. Ater six months´ treatment a 250% increase in SHBG was seen in desogestrel/EE group and no significant change in SHBG in levonorgestrel/EE group. However, at the same time serum free testosterone fell 60% in both treatment groups. SHBG cannot be the only regulator of serum free testosterone. Acne improved significantly in both treatment groups. It is likely that the improvement was in connection with the free testosterone decrease and the improvement was better in the desogestrel/EE group where also SHBG elevation was seen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Current data show no consistent difference in acne responses based on COC formulations or dosages and do not support the superiority of one COC over another for acne treatment”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [200]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
MALE HORMONE SUBSTANCE: A PRIME FACTOR IN ACNE1
Hamilton, J. B. (1941) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-1-7-570 · Cited by 134
Various Parameters for Grading Acne Vulgaris
Allen, B. S., & SMITH, J. G. (1982) · Archives of Dermatology · doi:10.1001/archderm.1982.01650130027012 · Cited by 104
Free testosterone concentration in serum: Elevation is the hallmark of hirsutism
Paulson, J. D., Keller, D. W., Wiest, W. G., & Warren, J. C. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90052-7 · Cited by 59
Androgen receptor in human skin
Bonne, C., Saurat, J. ‐., Chivot, M., LEHUCHET, D., & Raynaud, J. (1977) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1977.tb14126.x · Cited by 51
Plasma testosterone levels and acne
Förström, L., Mustakallio, K., Dessypris, A., Uggeldahl, P., & Adlercreutz, H. (1974) · Acta Dermato Venereologica · doi:10.2340/0001555554369371 · Cited by 49
Plasma androgens in acne vulgaris
LIM, L. S., & James, V. H. T. (1974) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1974.tb15858.x · Cited by 38
Various parameters for grading acne vulgaris
Allen, B. S. (1982) · Archives of Dermatology · doi:10.1001/archderm.118.1.23 · Cited by 10
STUDIES OF THE RELATION OF PLASMA ANDROGEN LEVELS TO ANDROGEN ACTION IN WOMEN
Rosenfield, R. L. (1976) · Elsevier eBooks · doi:10.1016/b978-0-08-019682-4.50090-1 · Cited by 1
Research works printed but not linked: 12
- [2]2. Bloch B. Metabolism, endocrien glands and skin diseases with special reference to acne vulgaris and lCanthoma. Br J Oermatol 1931; 43: 61-87.
- [4]4. Sansone G. Reisner RM. Differential rales of convcrsioo of testosterone to dihydrotestosterone in acne and in normal human skin-a possible pathogenic factor in acne J Invest Oermatol 1971; 56: 366---372.
- [6]6. Darley CR, Moore JW, Besser GM. Mindro 00. Androgen status in women with acne vulgaris. Br J Dermatol 1980; 103: 17.
- [7]7. Darley CR, Kirby JO, Besser GM, Mundro DD, Edwards CR. Rees LH. Circulating testosterone, sc1< hormone hindins globulin and prolactin in women with late onset or persistent acne vulgaris. Br J Dermatol 1982; 106: 517-522.
- [8]8. Lawrence DM. Katz T. Robinson WE, Newman MC, McGarrigle HH, Shaw M, Lachelin GC. Rcduced selC hormone binding globulin and derived free testosterone levels in women with severe acne. Clin Endocrinol 1982; 15: 87-91.
- [11]11. Hoffman E, Meiers HG, Hubles A. Wirkungen von Antikonseptiva auf Alopecia androgenetica, Seborrhoca oleosa, Akne vulgaris und Hirstutismus. Dtsch Med Wocheaschr 1971; 99:2151-2157.
- [17]17. Burke CW, Anderson DC. SelC hormone binding globulin as an estrogen amplifier. Nature 1972; 240: 38-40.
- [18]18. Moll GW, Rosenfield R-L. Some !imitations of using equilibrium dialysis 10 study human serum albumiatestosterone interaction. J Clin Endocrinol Metab 1978; 46: 501-503.
- [20]20. Bergink EW, Holma P, Pyörälä T. Effects of oral contraceptive combmations containing levonor gestrel or desogestrel on serum proteins and androgen binding. Scand J Clin Lab lnvest 1981; 41: 663-668.
- [21]21. Michelson KE. Petra PH. A Filter assay for the selC steroid binding protein of human serum. FEBS Lett 1974; 44: 34.
- [24]24. Saihan EM, Burton JL. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen thernpy. Br J Dermatol 1980; 103: 139-142.
- [25]25. Darley CR, Moore JW, Besser GM, Mundro DD, Kirby JD. Low dose prednisolone and oestrogen in the treatment of womcn with late onset or persistent acne vulgaris. Br J Dermatol 1983; 108: 345-353.
Cited by
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
Davis, S. R., Moreau, M., Kroll, R., Bouchard, C., Panay, N., Gass, M., Braunstein, G. D., Hirschberg, A. L., Rodenberg, C., Pack, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707302 · Cited by 479
Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., Waldbaum, A., Bouchard, C., Derzko, C., Buch, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1747 · Cited by 475
“73 phase] 300 g/d 281 79 [28, 332] 209 80 [30, 316] Total dihydrotestosterone [7–31 ng/dl] Placebo 272 7 [0, 14] 155 7 [0, 12] 0.”
Braunstein, G. D., Sundwall, D. A., Katz, M., Shifren, J. L., Buster, J. E., Simon, J. A., Bachman, G., Aguirre, O. A., Lucas, J. D., Rodenberg, C., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1582 · Cited by 458
Metadata
- Authors
- Palatsi, R., Hirvensalo, E., Liukko, P., Malmiharju, T., Mattila, L., Riihiluoma, P., & Ylöstalo, P.
- Affiliations
- North Karelia Central Hospital (FI)
- University of Turku (FI)
- University of Helsinki (FI)
- Venue
- Acta Dermato-Venereologica
- Publisher
- Medical Journals Sweden AB
- Published
- 1984-11-01
- Volume
- 64
- Issue
- 6
- Pages
- 517-523
- ISSN
- 0001-5555 (ISSN-L)
- 1651-2057
- OpenAlex
- W43582687
- Cited by
- 98
- References
- 8
- Citations by year
- 2024: 1 · 2021: 1 · 2020: 1 · 2015: 2 · 2014: 6 · 2013: 2 · 2012: 5
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Acta Dermato Venereologica (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- female acne, oral contraceptives, desogestrel, levonorgestrel, ethinyl estradiol, sex hormone-binding globulin, free testosterone, serum testosterone, acne severity
- MeSH terms
- Acne Vulgaris, Adolescent, Adult, Contraceptives, Oral, Contraceptives, Oral, Combined, Ethinyl Estradiol, Female, Humans, Norgestrel, Sex Hormone-Binding Globulin, Stereoisomerism, Testosterone, Levonorgestrel, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives. https://app.cochat.ai/papers/10.2340/0001555564517523
- The paper
- Palatsi, R., Hirvensalo, E., Liukko, P., Malmiharju, T., Mattila, L., Riihiluoma, P., & Ylöstalo, P. (1984). Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives. Acta Dermato-Venereologica. https://doi.org/10.2340/0001555564517523
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.